EDGAR Filing Documents for 0001047469-10-000310

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001047469-10-000310

Filing Date

2010-01-26

Accepted

2010-01-26 09:27:05

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	a2196017z20-f.htm	20-F	5894592
2	EXHIBIT 1.1	a2196017zex-1_1.htm	EX-1.1	222375
3	EXHIBIT 1.2	a2196017zex-1_2.htm	EX-1.2	201981
4	EXHIBIT 12.1	a2196017zex-12_1.htm	EX-12.1	13824
5	EXHIBIT 12.2	a2196017zex-12_2.htm	EX-12.2	13562
6	EXHIBIT 13.1	a2196017zex-13_1.htm	EX-13.1	8938
7	EX-14.1	a2196017zex-14_1.htm	EX-14.1	9380
8	G12362KWI001.JPG	g12362kwi001.jpg	GRAPHIC	4435
9	G462147.JPG	g462147.jpg	GRAPHIC	16249
	Complete submission text file	0001047469-10-000310.txt		6394758

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056

Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056

NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 10546187
SIC: 2834 Pharmaceutical Preparations